Encompass Health Corp Stock Filter Stocks by Fundamentals
| EHC Stock | USD 93.59 0.75 0.79% |
Encompass Health Corp fundamentals help investors to digest information that contributes to Encompass Health's financial success or failures. It also enables traders to predict the movement of Encompass Stock. The fundamental analysis module provides a way to measure Encompass Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Encompass Health stock.
Encompass | Shares Owned by Institutions |
Encompass Health ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Encompass Health's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Encompass Health's managers, analysts, and investors.Environmental | Governance | Social |
Encompass Health Institutional Holders
Institutional Holdings refers to the ownership stake in Encompass Health that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Encompass Health's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Encompass Health's value.| Shares | Geode Capital Management, Llc | 2024-09-30 | 1.7 M | Td Global Investment Solutions – Td Epoch | 2024-09-30 | 1.7 M | Hhg Plc | 2024-09-30 | 1.6 M | Brown Advisory Holdings Inc | 2024-09-30 | 1.5 M | Bank Of New York Mellon Corp | 2024-09-30 | 1.4 M | T. Rowe Price Associates, Inc. | 2024-09-30 | 1.3 M | Goldman Sachs Group Inc | 2024-09-30 | 1.3 M | Copeland Capital Management, Llc | 2024-09-30 | 1.3 M | Arrowstreet Capital Limited Partnership | 2024-09-30 | 1.1 M | Vanguard Group Inc | 2024-09-30 | 10.3 M | Blackrock Inc | 2024-06-30 | 9 M |
Encompass Fundamentals
| Return On Equity | 0.23 | ||||
| Return On Asset | 0.0838 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.15 % | ||||
| Current Valuation | 12.08 B | ||||
| Shares Outstanding | 100.75 M | ||||
| Shares Owned By Insiders | 1.36 % | ||||
| Shares Owned By Institutions | 98.36 % | ||||
| Number Of Shares Shorted | 1.27 M | ||||
| Price To Earning | 18.73 X | ||||
| Price To Book | 4.81 X | ||||
| Price To Sales | 1.81 X | ||||
| Revenue | 4.8 B | ||||
| Gross Profit | 1.75 B | ||||
| EBITDA | 1.02 B | ||||
| Net Income | 361.6 M | ||||
| Cash And Equivalents | 21.8 M | ||||
| Cash Per Share | 0.60 X | ||||
| Total Debt | 2.93 B | ||||
| Debt To Equity | 1.69 % | ||||
| Current Ratio | 1.21 X | ||||
| Book Value Per Share | 19.44 X | ||||
| Cash Flow From Operations | 850.8 M | ||||
| Short Ratio | 2.08 X | ||||
| Earnings Per Share | 4.25 X | ||||
| Price To Earnings To Growth | 1.37 X | ||||
| Target Price | 116.5 | ||||
| Number Of Employees | 27.48 K | ||||
| Beta | 0.78 | ||||
| Market Capitalization | 9.43 B | ||||
| Total Asset | 6.1 B | ||||
| Retained Earnings | 406.5 M | ||||
| Working Capital | 185.4 M | ||||
| Current Asset | 659.58 M | ||||
| Current Liabilities | 474.74 M | ||||
| Annual Yield | 0.01 % | ||||
| Five Year Return | 1.65 % | ||||
| Net Asset | 6.1 B | ||||
| Last Dividend Paid | 0.62 |
About Encompass Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Encompass Health Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Encompass Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Encompass Health Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Encompass Health Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Encompass Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Encompass Health Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Encompass Health Corp Stock:Check out Encompass Health Piotroski F Score and Encompass Health Altman Z Score analysis. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Encompass Health. If investors know Encompass will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Encompass Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.26 | Dividend Share 0.62 | Earnings Share 4.25 | Revenue Per Share 52.255 | Quarterly Revenue Growth 0.119 |
The market value of Encompass Health Corp is measured differently than its book value, which is the value of Encompass that is recorded on the company's balance sheet. Investors also form their own opinion of Encompass Health's value that differs from its market value or its book value, called intrinsic value, which is Encompass Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Encompass Health's market value can be influenced by many factors that don't directly affect Encompass Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Encompass Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Encompass Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Encompass Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.